Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIB Skin Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05270044
What this trial is testing

Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.

Who this might be right for
Melanoma
Pierre Fabre Medicament 815
Not applicableActive Not RecruitingNCT03677739
What this trial is testing

Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families

Who this might be right for
Clinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8+19 more
Rutgers, The State University of New Jersey 1,160
Large-scale testing (Phase 3)Ended earlyNCT01546571
What this trial is testing

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Who this might be right for
Melanoma
Polynoma LLC 504
Large-scale testing (Phase 3)WithdrawnNCT01826864
What this trial is testing

Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma

Who this might be right for
Stage IB MelanomaStage IIA MelanomaStage IIB Melanoma+1 more
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT01460875
What this trial is testing

Recombinant Interferon Alfa-2b in Treating Patients With Melanoma

Who this might be right for
Stage IA Skin MelanomaStage IB Skin MelanomaStage IIA Skin Melanoma+6 more
William Carson 34
Early research (Phase 1)Study completedNCT01456104
What this trial is testing

Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 9
Not applicableUnknownNCT00445783
What this trial is testing

Study of Families With Melanoma

Who this might be right for
Melanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 3,700
Early research (Phase 1)Study completedNCT00515983
What this trial is testing

Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells

Who this might be right for
Melanoma
José Mordoh, M.D., Ph.D. 16
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT00669019
What this trial is testing

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIA MelanomaStage IIB Melanoma+2 more
National Cancer Institute (NCI) 23
Very early researchStudy completedNCT01425749
What this trial is testing

Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI

Who this might be right for
Melanoma
Craig L Slingluff, Jr 25
Very early researchStudy completedNCT02320305
What this trial is testing

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

Who this might be right for
Stage IIA Skin MelanomaStage IIB Skin MelanomaStage IIC Skin Melanoma+4 more
Mayo Clinic 23
Large-scale testing (Phase 3)Active Not RecruitingNCT04309409
What this trial is testing

Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma

Who this might be right for
Malignant Melanoma Stage II
University Hospital, Essen 374
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Not applicableStudy completedNCT03028948
What this trial is testing

Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma

Who this might be right for
Stage 0 Skin MelanomaStage I Skin MelanomaStage IA Skin Melanoma+9 more
Rutgers, The State University of New Jersey 485
Large-scale testing (Phase 3)Active Not RecruitingNCT05608291
What this trial is testing

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 1,564
Not applicableStudy completedNCT03154190
What this trial is testing

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Who this might be right for
Acute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more
Stanford University 128
Large-scale testing (Phase 3)Active Not RecruitingNCT04099251
What this trial is testing

Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 790
Early research (Phase 1)Study completedNCT00698100
What this trial is testing

Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines

Who this might be right for
MelanomaSkin
Memorial Sloan Kettering Cancer Center 18
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Next Page